-
AMPK Inhibits Autophagy Initiation Under Energy Stress Condi
2026-06-03
This study redefines the canonical view of AMP-activated protein kinase (AMPK) in autophagy regulation, showing that AMPK suppresses rather than activates autophagy initiation in glucose-starved cells. These findings reshape our understanding of energy metabolism regulation and have practical implications for experimental approaches using AMPK activators.
-
GANT61: Precision GLI Inhibitor Workflows for Cancer Researc
2026-06-03
GANT61, a potent GLI inhibitor from APExBIO, enables reproducible, selective inhibition of GLI1/2 for dissecting Hedgehog pathway–driven tumor immune evasion. This article delivers actionable protocols, troubleshooting insights, and real-world use cases that set GANT61 apart for advanced cancer research and immunotherapy resistance modeling.
-
5-HT3 Antagonists Inhibit Renal OCT2 and MATE1 Transport In
2026-06-02
This study systematically evaluates the inhibitory effects of five 5-HT3 receptor antagonists—including tropisetron—on renal OCT2 and MATE1 transporters using cell-based in vitro models. The findings highlight a class effect on cationic drug secretion, with implications for drug-drug interactions in clinical settings and transporter-focused research.
-
Homoharringtonine: Cytotoxic Alkaloid Workflows in Cancer &
2026-06-02
Homoharringtonine, a potent cytotoxic alkaloid, is transforming both leukemia research and SARS-CoV-2 antiviral workflows by targeting eukaryotic ribosomes to halt protein synthesis. This article provides actionable guidance for experimental setups, protocol enhancements, and troubleshooting, drawing on the latest reference study and cross-domain innovations. Discover how APExBIO’s formulation streamlines reliable results in cancer biology and emerging virology assays.
-
Filipin III: Precision Cholesterol Detection in Membranes
2026-06-01
Filipin III, a polyene macrolide antibiotic, is the gold-standard probe for cholesterol detection in membranes. Its specificity and visualization capabilities underpin cell biology and membrane research, as substantiated by peer-reviewed and manufacturer data.
-
BMS-345541 Hydrochloride: Precision IKK Inhibitor in Inflamm
2026-06-01
BMS-345541 hydrochloride redefines NF-κB pathway inhibition with unmatched selectivity, empowering researchers to dissect inflammation and apoptosis mechanisms in vitro and in vivo. Its robust solubility and bioavailability make it a top-tier choice for targeted cytokine suppression and cancer biology workflows.
-
RNA Pol II Inhibition Drives Apoptosis Beyond Transcription
2026-05-31
Harper et al. (2025) reveal that cell death from RNA Pol II inhibition is not a passive consequence of mRNA decay but is triggered by an active apoptotic pathway sensing the loss of hypophosphorylated RNA Pol IIA. This mechanistic insight reframes how DNA damage response and cancer cell lethality are understood, with direct implications for the design and evaluation of targeted therapies.
-
Tropisetron Hydrochloride: 5-HT3 Receptor Antagonist Evidenc
2026-05-30
Tropisetron Hydrochloride is a potent 5-HT3 receptor antagonist used extensively in neuroscience receptor modulation. It exhibits an IC50 of 70.1 nM for the 5-HT3 receptor and is also an α7-nicotinic receptor agonist, supporting its application in serotonin signaling research.
-
PP 2 (AG 1879): Optimizing Src Kinase Inhibition in Cell Mod
2026-05-29
PP 2 (AG 1879) stands out as a nanomolar-selective Src family kinase inhibitor, enabling precise control over cell proliferation and invasion in cancer and immunology research. Here, we break down actionable workflows, highlight troubleshooting strategies, and translate a recent breakthrough on Src-mediated cytoskeletal signaling into practical assay enhancements.
-
Amphiregulin-Driven Fibrosis Sustains S. aureus Bone Abscess
2026-05-29
This study uncovers how amphiregulin from macrophages triggers myofibroblast transition in adipogenic precursors, constricting blood flow near S. aureus abscesses and hindering antibiotic efficacy in osteomyelitis. Targeting the macrophage–adipogenic precursor axis may improve treatment outcomes for chronic bone infections.
-
Z-YVAD-FMK: Precision Caspase-1 Inhibition in Pyroptosis Res
2026-05-28
Unlock the unique potential of Z-YVAD-FMK, a potent caspase-1 inhibitor, in dissecting pyroptotic and inflammatory cell death. This article offers a deeper, mechanistic analysis and practical guidance for advanced apoptosis and inflammasome activation studies.
-
25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re
2026-05-28
Xiao et al. (2024) identify lysosomal 25-hydroxycholesterol (25HC) as a pivotal regulator of tumor-associated macrophage (TAM) immunosuppressive function via AMPKα activation and STAT6 phosphorylation. Their findings reveal CH25H as an immunometabolic checkpoint and suggest targeting this axis can potentiate anti-tumor immunity, including in combination with anti-PD-1 therapy.
-
Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG
2026-05-27
This study elucidates how exposure to the carcinogen DNP induces a specific super-enhancer RNA (seRNA-NPCm), which in turn drives metastasis in nasopharyngeal carcinoma (NPC) by modulating the NPM1/c-Myc/NDRG1 axis. These findings provide mechanistic insights into enhancer RNA function in cancer progression and point toward new molecular targets for prognosis and intervention.
-
CCK-8 in Translational Neuroscience: Mechanisms, Metrics, an
2026-05-27
This thought-leadership article explores the mechanistic foundations and strategic applications of the Cell Counting Kit-8 (CCK-8) for translational researchers, focusing on its pivotal role in advancing cell viability and proliferation assays within neurodevelopmental and cancer research. By anchoring the discussion in recent evidence from ASD cellular models and integrating competitive insights, the article offers actionable guidance and a visionary outlook on assay optimization.
-
CGP 55845 Hydrochloride: Optimizing GABAB Antagonist Assays
2026-05-26
CGP 55845 hydrochloride, a potent GABAB receptor antagonist, is revolutionizing in vitro synaptic transmission research. This guide translates recent astrocyte-focused breakthroughs into actionable workflows, comparative advantages, and troubleshooting strategies for advanced neurotransmitter modulation studies.